180 related articles for article (PubMed ID: 10789724)
1. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
2. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.
Vincent F; Hagiwara K; Ke Y; Stoner GD; Demetrick DJ; Bennett WP
Biochem Biophys Res Commun; 1996 Jun; 223(3):561-4. PubMed ID: 8687435
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population.
Chung YJ; Song JM; Lee JY; Jung YT; Seo EJ; Choi SW; Rhyu MG
Cancer Res; 1996 Oct; 56(20):4662-5. PubMed ID: 8840981
[TBL] [Abstract][Full Text] [Related]
9. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
Grady WM; Myeroff LL; Swinler SE; Rajput A; Thiagalingam S; Lutterbaugh JD; Neumann A; Brattain MG; Chang J; Kim SJ; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
Cancer Res; 1999 Jan; 59(2):320-4. PubMed ID: 9927040
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
11. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
14. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
15. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
Lu SL; Kawabata M; Imamura T; Miyazono K; Yuasa Y
Biochem Biophys Res Commun; 1999 Jun; 259(2):385-90. PubMed ID: 10362519
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
18. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.
Myeroff LL; Parsons R; Kim SJ; Hedrick L; Cho KR; Orth K; Mathis M; Kinzler KW; Lutterbaugh J; Park K
Cancer Res; 1995 Dec; 55(23):5545-7. PubMed ID: 7585631
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
[TBL] [Abstract][Full Text] [Related]
20. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]